Ardena We are Ardena. A contract partner delivering drug development, manufacturing and bio-analysis services to clients globally. Pharmaceuticals

We are excited to introduce new content on our page –   ✨, featuring a series of interviews with our employees.Meet Cris...
16/05/2024

We are excited to introduce new content on our page – ✨, featuring a series of interviews with our employees.

Meet Cristina Montoya Irigoyen, our esteemed QA Qualification and Validation Coordinator based in Pamplona, Spain, with an impressive 18-year journey at Ardena.

💼 How would you describe yourself at Ardena?
– Determined, resolutive, and committed — these qualities drive my contributions each day.

🚀 Throughout my tenure spanning over 15 years, I've embarked on a dynamic professional journey, delving into various realms within Analytical Services, Manufacturing Systems, and Quality Assurance. Joining the Ardena family, I've had the opportunity to share my experience with all the other sites; simultaneously, I've also gleaned valuable insights from colleagues located in other countries. This exchange of knowledge and information is profoundly enriching and fruitful.

🏆 Reflecting Ardena's relentless pursuit of excellence, a standout moment was our recent ERP implementation—a challenge turned into a testament of teamwork and resilience. For me this set up the basis for every upcoming project.

🤝 What does "We CARE" mean to you?
– "We CARE" is an initiative that brings us an excellent opportunity to share our interests, values and knowledge. It also reinforces the fact that in order to succeed at work, the most important tools are communication, honesty and a strong commitment to quality.

🤝 For new team members venturing into their careers at Ardena, my advice is simple: Listen, learn, and embrace the wealth of knowledge shared by senior colleagues. Stay open-minded, and seize every chance to collaborate with colleagues across sites — it's these experiences that lay the foundation for remarkable careers at Ardena.

Join us: https://lnkd.in/g2ga6Vhy

hashtag

Last Friday, Ardena Ghent organized a quiz for the good cause Kom op tegen Kanker, or freely translated: Fight Against C...
22/11/2023

Last Friday, Ardena Ghent organized a quiz for the good cause Kom op tegen Kanker, or freely translated: Fight Against Cancer.
We can proudly say that this was a full Ardena event, as the evening was organised by a small team of Ardena colleagues and many more who volunteered to help throughout the evening.
The evening was a great success with 43 teams participating.
Thank you all!

24/10/2022

Five years ago - on October 24, 2017 - we launched the Ardena brand. Ardena was born from the merger of my company Pharmavize and the company Crystallics. Under the new brand, we began to pursue the goal of becoming a leading full-service contract developer of investigational drugs. So we developed an M&A strategy and sought out companies that offered complementary services to our core business. This was easier said than done: in the beginning, it felt like we had the picture of the puzzle, but not the pieces. But persistence pays off in the end. The companies ABL, Syntagon, ChemConnection and Idifarma shared our vision and joined the Ardena Group, with each company contributing a piece of the puzzle. Today, our multi-service platform offers a comprehensive "Develop, Make, Analyse, File" model, with services ranging from API, drug product and bioanalytical services to regulatory dossier development. We can act as a one-source partner and provide end-to-end solutions.

On the occasion of this 5th anniversary, I would like to take this opportunity to extend a heartfelt thank you to our 525-member international workforce. Over the years, your talent and efforts have been the foundation of our success. Thank you for always giving your best and being so dedicated to customer projects. The company is honoured to count on your dedication through thick and thin.

And of course, I thank our great customers. You have become an integral part of our story. We admire your innovation, determination and perseverance. Thank you for valuing our integrated service platform. It's our honour and privilege to be here for you. Like you, we are committed to bringing better medicines to patients faster.

Thank you all for making Ardena such a great brand!

Cheers,

Harry Christiaens, CEO

We are pleased to inform that construction has already started on our new aseptic fill and finish facility in Ghent, Bel...
04/05/2022

We are pleased to inform that construction has already started on our new aseptic fill and finish facility in Ghent, Belgium.

This will enable Ardena to extend our drug product services with the development and GMP manufacturing of injectable drugs for clinical trials (small and large molecules).

We will be providing future updates about the progress of the construction, and the technologies we will install in our brand new aseptic fill and finish facility until we manufacture our first batches.

More information available on our new website page: https://ardena.com/drug-product/services/aseptic-fill-finish/

12/04/2022

We recently issued our latest newsletter, highlighting our new whitepaper on nanoparticles analytics, our upcoming nanomedicines symposium and other relevant news and events where we will be participating.
Want to be updated about Ardena? Read the full newsletter here: https://lnkd.in/eXS49f2X

Click here to subscribe to future newsletters: https://lnkd.in/eK-uqUah

Congratulations to all Ardena colleagues who participated in the Sfinx EkidenRun event in Ghent this weekend! You are al...
22/03/2022

Congratulations to all Ardena colleagues who participated in the Sfinx EkidenRun event in Ghent this weekend! You are all champions! Super proud of the team which works together, executes together, succeeds together, runs together and parties together!

“This announcement will significantly enhance our ability to help Novavax deliver more vaccines. It makes me proud that ...
06/01/2022

“This announcement will significantly enhance our ability to help Novavax deliver more vaccines. It makes me proud that our company is part of the continuing innovation and multiple partnerships going on worldwide to tackle COVID-19.” - Harry Christiaens, CEO Ardena



Link to Press release:

Gent, Belgium/December 2021: Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO), announced it will be expanding its capacity for purification and fractionation of GMP manufacturing at its site in Södertälje, Sweden. The expansion will satisfy long-term d...

As the holidays approach and 2021 comes to an end, we at Ardena would like to wish you happy holidays and a wonderful 20...
24/12/2021

As the holidays approach and 2021 comes to an end, we at Ardena would like to wish you happy holidays and a wonderful 2022!

Ardena has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs. T...
02/09/2021

Ardena has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs. The acquisition from SUANFARMA delivers expansion across Southern Europe and supports Ardena’s strategy to become a leading global CDMO, offering integrated solutions across the full pharma development lifecycle.

"We’re delighted to partner with Ardena, to consolidate our leading position in drug development and clinical supply services”, explains Alfredo Gomez, CEO of Idifarma.

Harry Christiaens (CEO of Ardena) continues: “The Idifarma acquisition expands our pharmaceutical technology footprint, positioning Ardena to capitalise on the emerging biotech segment and broader pharmaceutical market."

Read the full press release here: https://ardena.com/news/press-release/ardena-acquires-idifarma-from-suanfarma-adding-spray-drying-technology-and-high-potency-capabilities/?utm_medium=social&utm_source=facebook&utm_campaign=PR-20210902-en&utm_content=idifarma

We are very pleased to announce that Peter Vermeylen will be joining Ardena as Corporate IT Director. In his role, Peter...
25/08/2021

We are very pleased to announce that Peter Vermeylen will be joining Ardena as Corporate IT Director. In his role, Peter will be responsible for the Ardena wide IT organisation and hence will oversee the entire IT staff at all Ardena sites. Welcome Peter!

It is with great pleasure that we announce a major €35 million investment for expansion across our European operations, ...
15/07/2021

It is with great pleasure that we announce a major €35 million investment for expansion across our European operations, in partnership with GHO Capital Partners LLP.

The investment will future proof offerings for the biopharma and emerging biotechnology sectors and positions Ardena to become a leading global CDMO, offering end-to-end solutions spanning the full pharma development lifecycle.

Ardena will significantly expand drug product services in Belgium and aseptic fill and finish capabilities for the development and clinical production of small molecule, injectable formulations. Capacity for large molecule biologics will expand to include Peptides, Oligonucleotides (DNA, recombinant RNA, synthetic RNA, RNA vaccines) and Proteins.

https://ardena.com/news/press-release-ardenas-success-leads-to-major-e35-million-investment-for-expansion-in-belgium-sweden-and-the-netherlands/?utm_medium=social&utm_source=facebook&utm_campaign=PR-20210714-en&utm_content=gho_investment

Sinds 18/02/2021 voorziet Ardena Gent wekelijkse speekseltesten van Biogazelle voor 50 van de 92 werknemers die on-site ...
21/04/2021

Sinds 18/02/2021 voorziet Ardena Gent wekelijkse speekseltesten van Biogazelle voor 50 van de 92 werknemers die on-site moeten werken. Dit voor de veiligheid van het personeel en de continuïteit van onze services.
"Het zorgt voor een veiligere sfeer op het werk en het is een geruststelling voor de mensen binnen mijn bubbel dat ze weten dat ik negatief getest heb." - Karen Herman, Associate Scientist - Analytical Development

https://www.avs.be/artikels/speekseltesten-op-de-werkvloer-zijn-een-succes-a80559

De speekseltest, ontwikkeld door het Gentse bedrijf Biogazelle, heeft de afgelopen weken zijn nut bewezen. De test detecteerde al verschillende coronabesmettingen bij werknemers zonder symptomen. Op die manier zijn grote uitbraken vermeden.

Adres

Mariakerke

Openingstijden

Maandag 08:30 - 17:00
Dinsdag 08:30 - 17:00
Woensdag 08:30 - 17:00
Donderdag 08:30 - 17:00
Vrijdag 08:30 - 17:00

Telefoon

+3292676500

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Ardena nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar Ardena:

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram